查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1764704

立体定位神经导航系统市场 - 全球及区域分析：按产品、应用、最终用户及区域 - 分析与预测（2025-2035 年）

Stereotactic Neuro-Navigation System Market - A Global and Regional Analysis: Focus on Product, Application, End User, and Region - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 126 Pages | 商品交期: 1-5个工作天内

价格

预计 2024 年全球立体定位神经导航系统市场规模将达 8.407 亿美元。

预计到 2035 年市场规模将激增至 31.03 亿美元， 年复合成长率至 2035 年期间复合年增长率将达到 12.92%，呈现显着成长。

主要市场统计数据
预测期 2025-2035
2025年评估 9.201亿美元
2035年的预测 31.3亿美元
复合年增长率 12.92%

受神经系统疾病盛行率上升、导航辅助手术优于传统手术以及转变为微创手术的推动，市场持续以两位数的速度成长。

包括人工智慧 (AI)、机器学习 (ML) 和扩增实境(AR) 的整合在内的技术进步正在提高手术精度并扩展这些系统的功能。此外，微创手术 (MIS) 的日益普及也推动了对更先进、更精确的导航工具的需求。由于人口老化，需要手术治疗的与老龄化相关的神经系统疾病的增加也推动了市场的发展。然而，这些系统的高价格、整合的复杂性以及手术期间的潜在併发症等挑战可能会阻碍市场的成长。儘管存在这些挑战，但持续的技术创新、有利的监管支援以及神经外科和其他专业的日益增长的应用预计将刺激市场的持续扩张。

市场介绍

立体定位神经导航系统市场正在快速发展，这得益于技术创新和策略联盟的推动，这些联盟旨在提高手术精度和患者治疗效果。美敦力与Brainlab等合作伙伴关係率先推出了整合式导航解决方案，该解决方案将即时影像处理与先进的手术计划相结合，以提高神经外科手术的精度。同时，像Orthofix Medical这样的公司正在透过开发神经导航系统来扩展其产品组合，以促进微创脊椎手术。最近推出的产品，包括史赛克的颅脑导航系统，提供了增强的可视化和扩增实境功能，以支援复杂的肿瘤切除术。此外，Brainlab收购Novalis Circle等收购整合了专业知识和技术，有望推动市场强劲成长。这些发展支撑了对高精度神经外科手术工具日益增长的需求，推动了该领域的创新和临床应用的成长。

对产业的影响

全球立体定位神经导航系统市场由美敦力、Brainlab、Stryker和Orthofix Medical Inc.等领导企业主导。透过将即时导航与MRI和CT等先进影像技术相结合，这些公司为肿瘤切除、深部脑部刺激和癫痫治疗等精准脑外科手术提供全面的解决方案。美敦力的StealthStation和Brainlab的Curve导航系统等产品体现了这种技术整合，提高了手术精度并降低了手术风险。该行业的影响涵盖临床神经外科、研究和培训，促进了微创手术并改善了患者预后。透过持续的技术创新和不断拓展的临床应用，立体定位神经导航市场正在显着推动全球神经外科治疗的发展。

市场区隔

细分 1：按产品

  • 神经导航系统
  • 立体定位框架单元

从产品角度来看，全球立体定位神经导航系统市场将由神经导航系统驱动，到2024年将占据80.9%的市场。该领域占据市场主导地位的关键原因是其技术力、准确性提升以及在现代外科手术中日益增强的多功能性。神经导航系统利用即时3D成像以及与MRI、 电脑断层扫描和超音波等先进技术的集成，在手术过程中提供精准的动态引导。这使得其在定位和导航大脑和脊髓复杂区域方面拥有卓越的精确度，这对于最大限度地减少併发症和改善患者预后至关重要。

细分2：按应用

  • 颅骨
  • 脊髓

从应用类型来看，全球立体定位神经导航系统市场主要由脊椎领域驱动，2024 年占 62.6%。由于退化性疾病、脊椎畸形和创伤等脊椎疾病发生率高，需要频繁的外科手术干预，因此脊椎应用在神经导航系统市场中占据主导地位。微创脊椎手术 (MISS) 的日益普及进一步刺激了市场需求，因为这些手术需要神经导航系统提供的高精度支援。此外，脊椎手术的复杂性以及日益增长的老化人口面临与老龄化相关的脊椎问题，也促使脊椎导航系统的使用率不断上升。这些因素共同推动脊椎应用在市场中超越颅脑应用。

细分 3：按最终用户

  • 医院
  • 麻醉学

按最终用户划分，全球立体定位神经导航系统市场由医院部门推动，2024 年的份额为 91.9%。医院在最终用户的神经导航系统市场中占据主导地位，因为它们在提供全面的外科护理方面发挥着核心作用，并且能够处理复杂和大批量的手术。医疗保健机构，尤其是学术医疗中心和大型医疗机构，配备了先进的基础设施、熟练的医疗专业人员以及神经外科、整形外科和脊椎外科等专科部门，这推动了对神经导航系统的需求。这些系统对于执行精确和微创手术至关重要，从而改善患者的预后并缩短復原时间。此外，医院通常执行更多的手术，从常规手术到复杂手术，这进一步增强了它们的市场主导地位。医院投资最尖端科技和采用导航系统多学科应用的能力使其成为该市场成长的关键参与者。

细分4：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 其他的
  • 其他地区

预计北美地区的立体定位神经导航系统市场在预测期内将达到12.36%的显着成长率。这一显着增长得益于几个关键因素，包括先进的医疗基础设施、创新技术的高采用率以及强大的研发能力。该地区拥有一些世界领先的医院、医疗中心和学术机构，拥有最先进的设备和高技能的专业人员。这些基础设施促进了神经导航系统等最尖端科技的采用。此外，北美脊椎和颅脑疾病的发生率很高，这增加了对精准外科手术的需求。该地区的医疗保健系统提供了广泛的先进治疗途径，从而促进了微创手术的应用，而神经导航在这些手术中至关重要。此外，美国和加拿大拥有完善的法规环境和对技术创新的大力支持，Medtronic和史赛克等公司主导神经导航技术的开发，进一步巩固了北美在该市场的领先地位。

立体定位神经导航系统市场的最新趋势

  • 2024年9月，史赛克公司收购了NICO公司，非上市公司，致力于为肿瘤和脑出血(ICH)手术提供系统性微创手术。此次收购增强了史赛克对神经技术领域的投入，尤其是在肿瘤和中风治疗领域。
  • 2024 年 5 月，AiM Robotics 与 Synaptive Medical 合作，将其神经导航软体 Modus Nav 整合到神经外科机器人中，以改善视觉化、导航和控制。
  • 2023年7月，史赛克公司推出了搭载颅脑引导软体的Q引导系统。

需求——驱动因素、挑战、机会

市场驱动因素：

  • 神经系统疾病盛行率上升：神经系统疾病盛行率上升是立体定位神经导航市场的主要驱动力。随着脑肿瘤、癫痫和巴金森氏症等疾病的全球发生率上升，对精准外科手术的需求也随之增加。例如，根据健康数据 (Health Data) 的数据，到 2021 年，约有 34 亿人将患有影响神经系统的疾病。立体定位神经导航系统具有高精度和微创性，正越来越多地被用于应对这些挑战。此外，神经系统疾病是全球疾病负担的首要原因。此外，全球人口正在老化，导致与老龄化相关的神经系统疾病增加。这些人口结构变化导致对神经外科手术的需求增加，进而对先进的神经导航技术的需求也随之增加。随着全球人口老化，与老龄化相关的神经系统疾病（如失智症和帕金森氏症）的发生率也在上升。这导致需要手术干预治疗这些疾病的患者数量增加。随着对外科治疗的需求增加，对指导这些复杂手术的准确可靠的神经导航系统的需求也在增加。

市场挑战：

  • 与使用导航系统相关的併发症：神经导航系统透过提高精确度、安全性和效率彻底改变了神经外科手术，但其使用并非没有併发症。与任何先进技术一样，导航系统在神经外科手术中的整合也面临挑战。在导航辅助神经外科手术中，器械的进入点和轨迹都定义明确，但由于手动攻丝和插入，在螺丝插入过程中可能会出现不准确，导致轴向摆动和最大径向偏移。为了缓解这种情况，最好将螺丝插入延迟到所有计划的轨迹都完成之后。现在可以使用动力椎弓根螺钉驱动系统，透过提供更快、更准确的螺钉插入来改善外科医生的体验。

市场机会：

  • 人工智慧 (AI) 与机器学习的融合：人工智慧 (AI) 和机器学习 (ML) 技术为神经外科的整合提供了巨大的机会和变革能力。这些技术在多个关键应用中发挥关键作用，例如透过分割术中影像来增强导航系统，尤其是在精确放置椎弓根螺钉方面。此外，ML 演算法在解释椎间盘影像和全脊椎X光相片方面发挥关键作用，有助于实现临床医生诊断程序的自动化和简化。此外，虚拟实境 (VR) 和扩增实境(AR) 系统与外科培训计画的整合已经显示出良好的效果。这些先进技术为受训人员提供了身临其境型学习体验，使他们能够在逼真的虚拟环境中模拟外科手术过程。研究表明，这种身临其境型训练与缩短手术时间和提高受训人员整体表现有关，凸显了 VR 和 AR 在加强外科教育和提高熟练程度方面的价值。

产品/创新策略：全球立体定位神经导航系统市场已根据产品应用领域、最终用户、地区等不同类别进行广泛细分。这有助于读者清楚了解哪个细分市场占有最大份额以及哪个细分市场在未来几年可能会成长。

成长/行销策略：伙伴关係、联盟和共同开发占主要发展的大部分，即 2020 年 1 月至 2025 年 4 月全球立体定向神经导航系统市场的发展占总量的近 35.0%。

竞争策略：全球立体定位神经导航系统市场现有众多参与者及其产品系列。本研究分析并概述了全球立体定位神经导航系统市场中的主要企业概况，包括现有提供立体定位神经导航系统产品的公司。

目录

执行摘要

第一章市场：产业展望

  • 市场趋势
  • 赎回方案
  • 专利分析
  • 监管状况/合规性
  • 供应链分析
  • 定价分析
  • 市场动态

2. 全球立体定位神经导航系统市场（按产品），百万美元，2023-2035 年

  • 神经导航系统
    • 隐形站导航
    • 曲线导航
    • Q导引系统
    • 简易导航
    • 7D手术系统
    • Xvision-Spine 系统
    • 卡杜塞斯 S (AR)
  • 立体定位框架单元

3. 全球立体定位神经导航系统市场（按应用），百万美元，2023-2035 年

  • 脊椎
  • 颅骨

4. 全球立体定位神经导航系统市场（按最终用户划分），百万美元，2023 年至 2035 年

  • 医院、诊所
  • 门诊手术中心（ASC）

5. 全球立体定位神经导航系统市场（按地区划分），百万美元，2023-2035 年

  • 北美洲
    • 区域概况
    • 市场成长动力
    • 成长抑制因素
    • 美国
    • 加拿大
  • 欧洲
    • 区域概况
    • 市场成长动力
    • 成长抑制因素
    • 英国
    • 德国
    • 法国
    • 其他的
  • 亚太地区
    • 区域概况
    • 市场成长动力
    • 成长抑制因素
    • 日本
    • 中国
    • 其他的
  • 其他地区
    • 区域概况
    • 市场成长动力
    • 成长抑制因素

6. 市场竞争基准化分析与公司概况

  • 关键策略和发展
  • 产品基准
  • 市场占有率
  • 公司简介
    • Medtronic Plc
    • Brainlab AG
    • ClearPoint Neuro, Inc.
    • Elekta
    • Stryker Corporation
    • Orthofix Medical Inc
    • SaphireX Surgicals
    • FHC
    • Integra LifeSciences Corporation
    • SURGLASSES Inc.
    • HRS Navigation
    • Augmedics

第七章调查方法

Product Code: BHR3045SA

This report can be delivered within 1 working day.

Introduction of Stereotactic Neuro-Navigation System Market

The global stereotactic neuro-navigation system market, initially valued at $840.7 million in 2024, is projected to witness substantial growth, surging to $3,100.3 million by 2035, marking a remarkable compound annual growth rate (CAGR) of 12.92% over the period from 2025 to 2035.

KEY MARKET STATISTICS
Forecast Period2025 - 2035
2025 Evaluation$920.1 Million
2035 Forecast$3,100.3 Million
CAGR12.92%

The market has been witnessing double-digit growth, driven by the rising prevalence of neurological disorders, benefits offered by navigation-assisted surgeries over conventional surgeries, and a shift toward minimally invasive surgery.

Technological advancements, including the integration of artificial intelligence (AI), machine learning (ML), and augmented reality (AR), have been enhancing surgical precision and expanding the capabilities of these systems. Additionally, the increasing adoption of minimally invasive surgery (MIS) has been driving the demand for more advanced and accurate navigation tools. The market is also bolstered by a growing aging population, leading to an increase in age-related neurological conditions that require surgical treatment. However, challenges such as the high cost of these systems, integration complexities, and potential complications during surgery may hinder market growth. Despite these challenges, ongoing innovation, favorable regulatory support, and expanding applications in neurosurgery and other specialties are expected to fuel continued market expansion.

Market Introduction

The stereotactic neuro-navigation system market has been rapidly advancing, driven by technological innovations and strategic collaborations that enhance surgical precision and patient outcomes. Partnerships, such as Medtronic's collaboration with Brainlab, have been pioneering integrated navigation solutions that combine real-time imaging with advanced surgical planning, thereby improving accuracy in neurosurgical procedures. Meanwhile, companies such as Orthofix Medical have been expanding their portfolio through the development of neuro-navigation system, facilitating minimally invasive spine surgeries. Recent product launches, including Stryker's Cranial Navigation System, offer enhanced visualization and augmented reality features that support complex tumor resections. Additionally, acquisitions such as Brainlab's acquisition of Novalis Circle are consolidating expertise and technology, positioning the market for robust growth. These developments underscore the increasing demand for precision neurosurgery tools, driving innovation and expanding clinical applications in the field.

Industrial Impact

The global stereotactic neuro-navigation system market, driven by industry leaders such as Medtronic, Brainlab, Stryker, and Orthofix Medical Inc., has been transforming the landscape of neurosurgical interventions. By integrating advanced imaging modalities such as MRI and CT with real-time navigation, these companies provide comprehensive solutions for precise brain surgeries, including tumor resections, deep brain stimulation, and epilepsy treatment. Products such as Medtronic's StealthStation and Brainlab's Curve Navigation System exemplify this technological integration, enhancing surgical accuracy and reducing operative risks. The industrial impact extends across clinical neurosurgery, research, and training, facilitating minimally invasive procedures and improving patient outcomes. Through continuous innovation and expanding clinical applications, the stereotactic neuro-navigation market has been driving significant advancements in neurosurgical care globally.

Market Segmentation:

Segmentation 1: by Product

  • Neuro-Navigation System
  • Stereotactic Frame Units

Neuro-Navigation Systems Segment to Dominate the Stereotactic Neuro-Navigation System Market (by Product)

Based on product, the global stereotactic neuro-navigation system market was led by the neuro-navigation system, which held an 80.9% share in 2024. The segment dominates the market primarily due to its advanced technological capabilities, enhanced precision, and increased versatility in modern surgical practices. Neuro-navigation systems utilize real-time 3D imaging and advanced integration with modalities such as MRI, CT scans, and ultrasound to provide precise, dynamic guidance during surgery. This offers superior accuracy in targeting and navigating complex areas of the brain and spinal cord, which is essential for minimizing complications and improving patient outcomes.

Segmentation 2: by Application

  • Cranial
  • Spinal

Spinal Segment to Dominate the Stereotactic Neuro-Navigation System Market (by Application)

Based on application type, the global stereotactic neuro-navigation system market was led by the spinal segment, which held a 62.6% share in 2024. Spinal applications dominate the neuro-navigation system market due to the higher incidence of spinal conditions, such as degenerative diseases, spinal deformities, and trauma, which require frequent surgical intervention. The increasing adoption of minimally invasive spine surgery (MISS) further drives demand, as these procedures require enhanced precision, which neuro-navigation systems provide. Additionally, the complexity of spinal surgeries, combined with the growing aging population facing age-related spinal issues, contributes to the greater utilization of spinal navigation systems. These factors collectively make spinal applications the leading segment in the market over cranial applications.

Segmentation 3: by End User

  • Hospitals
  • ASCs

Hospital Segment to Dominate the Stereotactic Neuro-Navigation System Market (by End User)

Based on end user, the global stereotactic neuro-navigation system market was led by the hospital segment, which held a 91.9% share in 2024. Hospitals dominate the neuro-navigation system market based on end-users due to their central role in providing comprehensive surgical care and their capacity to handle complex and high-volume surgeries. Hospitals, especially academic medical centers, and large healthcare facilities, are equipped with advanced infrastructure, skilled medical professionals, and specialized departments such as neurosurgery, orthopedics, and spinal surgery, which drive the demand for neuro-navigation systems. These systems are essential for performing precise, minimally invasive surgeries, thereby improving patient outcomes and reducing recovery times, all of which are crucial for hospitals striving to deliver the best care. Additionally, hospitals generally conduct a higher volume of surgeries, ranging from routine to complex procedures, which further contributes to their market dominance. The ability of hospitals to invest in cutting-edge technology and adopt multi-specialty applications of navigation systems makes them key players in the growth of this market.

Segmentation 4: by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Rest-of-Europe
  • Asia-Pacific
    • Japan
    • China
    • Rest-of-Asia-Pacific
  • Rest-of-the-World

The stereotactic neuro-navigation system market in the North America region is expected to witness a significant growth rate of 12.36% during the forecast period. This notable growth can be attributed to several key factors, including advanced healthcare infrastructure, high adoption of innovative technologies, and strong research and development capabilities. The region is home to some of the world's leading hospitals, medical centers, and academic institutions, which are equipped with state-of-the-art facilities and highly skilled professionals. This infrastructure facilitates the adoption of cutting-edge technologies such as neuro-navigation systems. Additionally, North America has a high prevalence of spinal and cranial conditions, which increases the demand for precise surgical interventions. The region's healthcare system, which provides wide access to advanced treatments, drives the use of minimally invasive surgeries where neuro-navigation is essential. Furthermore, the U.S. and Canada have robust regulatory environments and strong support for innovation, with companies such as Medtronic and Stryker leading the development of neuro-navigation technologies, thereby further cementing North America's leadership in this market.

Recent Developments in the Stereotactic Neuro-Navigation System Market

  • In September 2024, Stryker Corporation acquired NICO Corporation, a privately held firm offering a systematic approach to minimally invasive surgery for tumor and intracerebral hemorrhage (ICH) procedures. This acquisition reinforces Stryker's commitment to neurotechnology, particularly in tumor and stroke care.
  • In May 2024, AiM Robotics partnered with Synaptive Medical to integrate the Modus Nav neuro-navigation software into its neurosurgery robot, improving visualization, navigation, and control.
  • In July 2023, Stryker Corporation launched the Q Guidance System with Cranial Guidance Software.

Demand - Drivers, Challenges, and Opportunities

Market Drivers:

  • Rising Prevalence of Neurological Disorder: The rising prevalence of neurological disorders is a significant driver of the stereotactic neuro-navigation market. As the global incidence of conditions such as brain tumors, epilepsy, and Parkinson's disease increases, the demand for precise surgical interventions has escalated. For instance, as per the Health Data, around 3.40 billion individuals had conditions affecting the nervous system in 2021. Stereotactic neuro-navigation systems, which offer high accuracy and minimal invasiveness, are increasingly utilized to address these challenges. Moreover, neurological conditions are the number one leading cause of disease burden worldwide. Moreover, the global population has been aging, leading to an increase in age-related neurological conditions. This demographic shift is contributing to a higher demand for neurosurgical interventions and, consequently, for advanced neuro-navigation technologies. As the global population ages, the incidence of age-related neurological diseases, such as dementia and Parkinson's disease, rises. This contributes to a larger patient base requiring surgical intervention for these conditions. As the demand for surgical treatments increases, so does the demand for accurate, reliable neuro-navigation systems to guide these complex procedures.

Market Challenges:

  • Complications Associated with the Use of Navigation Systems: While neuro-navigation systems have revolutionized neurosurgery by enhancing precision, safety, and efficiency, their use does not come without complications. Like any advanced technology, the integration of navigation systems in neurosurgery has its challenges. In navigation-assisted neuro surgeries, while entry points and trajectories for instrumentation are clearly defined, inaccuracies may arise during screw insertion due to manual tapping or insertion, leading to wobbling and maximal radial movement from the center of the axis. To mitigate this, it is advisable to delay screw insertion until after all planned trajectories have been created. Presently, powered pedicle screw drive systems are available, offering faster and more accurate screw insertions, thereby enhancing the surgeon's experience.

Market Opportunities:

  • Integration of Artificial Intelligence (AI) and Machine Learning: AI and machine learning (ML) techniques present significant opportunities for integration within neurosurgery, offering transformative capabilities. These technologies are pivotal in several key applications, including the segmentation of intraoperative images to enhance navigation systems, especially in the precise placement of pedicle screws. Moreover, ML algorithms play a vital role in the interpretation of images depicting intervertebral discs or full spine radiographs, facilitating automation and streamlining diagnostic procedures for clinicians. Furthermore, the integration of virtual reality (VR) and augmented reality (AR) systems into surgical training programs has already shown promising outcomes. These advanced technologies provide immersive learning experiences for trainees, enabling them to simulate surgical procedures in realistic virtual environments. Studies have indicated that such immersive training correlates with improved operative times and overall performance among trainees, underscoring the value of VR and AR in enhancing surgical education and proficiency.

How can this report add value to an organization?

Product/Innovation Strategy: The global stereotactic neuro-navigation system market has been extensively segmented based on various categories, such as product application area, end user, and region. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Growth/Marketing Strategy: Partnerships, alliances, and collaborations accounted for the maximum number of key developments, i.e., nearly 35.0% of the total developments in the global stereotactic neuro-navigation system market were between January 2020 and April 2025.

Competitive Strategy: The global stereotactic neuro-navigation system market has numerous established players with product portfolios. Key players in the global stereotactic neuro-navigation system market analyzed and profiled in the study include established players offering products for stereotactic neuro-navigation systems.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • The base year considered for the calculation of the market size is 2024. A historical year analysis has been done for the period FY2020-FY2023. The market size has been estimated for FY2024 and projected for the period FY2025-FY2035.
  • The scope of this report has been carefully derived based on interactions with experts in different companies across the world. This report presents a comprehensive market study of the upstream and downstream products in the stereotactic neuro-navigation system market.
  • The market contribution of stereotactic neuro-navigation systems is anticipated to be launched in the future and has been calculated based on the historical analysis of the solutions.
  • Revenues of the companies have been referenced from their annual reports for FY2023 and FY2024. For private companies, revenues have been estimated based on factors such as inputs obtained from primary research, funding history, market collaborations, and operational history.
  • The market has been mapped based on the available stereotactic neuro-navigation systems. All the key companies with significant offerings in this field have been considered and profiled in this report.

Primary Research:

The primary sources involve industry experts in stereotactic neuro-navigation systems, including the market players offering products and services. Resources such as CEOs, vice presidents, marketing directors, and technology and innovation directors have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

  • Validation and triangulation of all the numbers and graphs
  • Validation of the report's segmentation and key qualitative findings
  • Understanding the competitive landscape and business model
  • Current and proposed production values of a product by market players
  • Validation of the numbers of the different segments of the market in focus
  • Percentage split of individual markets for regional analysis

Secondary Research:

Open Sources

  • Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
  • Annual reports, SEC filings, and investor presentations of the leading market players
  • Company websites and detailed study of their product portfolio
  • Gold standard magazines, journals, white papers, press releases, and news articles

Paid databases

The key data points taken from the secondary sources include:

  • Segmentations and percentage shares
  • Data for market value
  • Key industry trends of the top players of the market
  • Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • Quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from primary experts and an analysis of company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • Medtronic Plc
  • Brainlab AG
  • ClearPoint Neuro, Inc.
  • Elekta
  • Stryker Corporation
  • Orthofix Medical Inc.
  • Saphirex Surgicals
  • FHC
  • Integra LifeSciences Corporation

Table of Contents

Executive Summary

Scope and Definition

1 Market: Industry Outlook

  • 1.1 Market Trends
    • 1.1.1 Leveraging Synergies to Diversify Business Portfolio
  • 1.2 Reimbursement Scenario
  • 1.3 Patent Analysis
  • 1.4 Regulatory Landscape/Compliance
    • 1.4.1 U.S.
    • 1.4.2 Europe
      • 1.4.2.1 U.K.
    • 1.4.3 Japan
    • 1.4.4 China
    • 1.4.5 Rest-of-the-World (RoW)
  • 1.5 Supply Chain Analysis
  • 1.6 Pricing Analysis
  • 1.7 Market Dynamics
    • 1.7.1 Market Drivers
      • 1.7.1.1 Rising Prevalence of Neurological Disorders
      • 1.7.1.2 Benefits Offered by Navigation-Assisted Surgeries Over Conventional Surgeries
    • 1.7.2 Market Restraints
      • 1.7.2.1 Complications Associated with the Use of Navigation Systems
      • 1.7.2.2 High Cost of Acquisition
    • 1.7.3 Market Opportunities
      • 1.7.3.1 Integration of Artificial Intelligence (AI) and Machine Learning

2 Global Stereotactic Neuro-navigation System Market (By Product), $Million, 2023-2035

  • 2.1 Neuro-Navigation System
    • 2.1.1 Stealth Station Navigation
      • 2.1.1.1 Overview
      • 2.1.1.2 Installed Base
      • 2.1.1.3 Average Selling Price
      • 2.1.1.4 Unit Sold
      • 2.1.1.5 Market Sizing and Forecast
    • 2.1.2 Curve Navigation
      • 2.1.2.1 Overview
      • 2.1.2.2 Installed Base
      • 2.1.2.3 Average Selling Price
      • 2.1.2.4 Unit Sold
      • 2.1.2.5 Market Sizing and Forecast
    • 2.1.3 Q Guidance System
      • 2.1.3.1 Overview
      • 2.1.3.2 Installed Base
      • 2.1.3.3 Average Selling Price
      • 2.1.3.4 Unit Sold
      • 2.1.3.5 Market Sizing and Forecast
    • 2.1.4 easyNav
      • 2.1.4.1 Overview
      • 2.1.4.2 Installed Base
      • 2.1.4.3 Average Selling Price
      • 2.1.4.4 Unit Sold
      • 2.1.4.5 Market Sizing and Forecast
    • 2.1.5 7D Surgical System
      • 2.1.5.1 Overview
      • 2.1.5.2 Installed Base
      • 2.1.5.3 Average Selling Price
      • 2.1.5.4 Unit Sold
      • 2.1.5.5 Market Sizing and Forecast
    • 2.1.6 Xvision-Spine System
      • 2.1.6.1 Overview
      • 2.1.6.2 Installed Base
      • 2.1.6.3 Average Selling Price
      • 2.1.6.4 Unit Sold
      • 2.1.6.5 Market Sizing and Forecast
    • 2.1.7 Caduceus S (AR)
      • 2.1.7.1 Overview
      • 2.1.7.2 Average Selling Price
      • 2.1.7.3 Unit Sold
      • 2.1.7.4 Market Sizing and Forecast
  • 2.2 Stereotactic Frame Units

3 Global Stereotactic Neuro-navigation System Market (By Application), $Million, 2023-2035

  • 3.1 Spinal
  • 3.2 Cranial

4 Global Stereotactic Neuro-navigation System Market (By End User), $Million, 2023-2035

  • 4.1 Hospitals and Clinics
  • 4.2 Ambulatory Surgical Centers (ASCs)

5 Global Stereotactic Neuro-navigation System Market (By Region), $Million, 2023-2035

  • 5.1 North America
    • 5.1.1 Regional Overview
    • 5.1.2 Driving Factors for Market Growth
    • 5.1.3 Factors Challenging the Market
    • 5.1.4 U.S.
    • 5.1.5 Canada
  • 5.2 Europe
    • 5.2.1 Regional Overview
    • 5.2.2 Driving Factors for Market Growth
    • 5.2.3 Factors Challenging the Market
    • 5.2.4 U.K.
    • 5.2.5 Germany
    • 5.2.6 France
    • 5.2.7 Rest of the Europe
  • 5.3 Asia Pacific
    • 5.3.1 Regional Overview
    • 5.3.2 Driving Factors for Market Growth
    • 5.3.3 Factors Challenging the Market
    • 5.3.4 Japan
    • 5.3.5 China
    • 5.3.6 Rest-of-Asia-Pacific
  • 5.4 Rest-of-the-World
    • 5.4.1 Regional Overview
    • 5.4.2 Driving Factors for Market Growth
    • 5.4.3 Factors Challenging the Market

6 Markets - Competitive Benchmarking & Company Profiles

  • 6.1 Key Strategies and Development
  • 6.2 Product Benchmarking
  • 6.3 Market Share
  • 6.4 Company Profiles
    • 6.4.1 Medtronic Plc
      • 6.4.1.1 Overview
      • 6.4.1.2 Top Products/Product Portfolio
      • 6.4.1.3 Top Competitors
      • 6.4.1.4 Target Customers
      • 6.4.1.5 Key Personal
      • 6.4.1.6 Analyst View
    • 6.4.2 Brainlab AG
      • 6.4.2.1 Overview
      • 6.4.2.2 Top Products/Product Portfolio
      • 6.4.2.3 Top Competitors
      • 6.4.2.4 Target Customers
      • 6.4.2.5 Key Personal
      • 6.4.2.6 Analyst View
    • 6.4.3 ClearPoint Neuro, Inc.
      • 6.4.3.1 Overview
      • 6.4.3.2 Top Products/Product Portfolio
      • 6.4.3.3 Top Competitors
      • 6.4.3.4 Target Customers
      • 6.4.3.5 Key Personal
      • 6.4.3.6 Analyst View
    • 6.4.4 Elekta
      • 6.4.4.1 Overview
      • 6.4.4.2 Top Products/Product Portfolio
      • 6.4.4.3 Top Competitors
      • 6.4.4.4 Target Customers
      • 6.4.4.5 Key Personal
      • 6.4.4.6 Analyst View
    • 6.4.5 Stryker Corporation
      • 6.4.5.1 Overview
      • 6.4.5.2 Top Products/Product Portfolio
      • 6.4.5.3 Top Competitors
      • 6.4.5.4 Target Customers
      • 6.4.5.5 Key Personal
      • 6.4.5.6 Analyst View
    • 6.4.6 Orthofix Medical Inc
      • 6.4.6.1 Overview
      • 6.4.6.2 Top Products/Product Portfolio
      • 6.4.6.3 Top Competitors
      • 6.4.6.4 Target Customers
      • 6.4.6.5 Key Personal
      • 6.4.6.6 Analyst View
    • 6.4.7 SaphireX Surgicals
      • 6.4.7.1 Overview
      • 6.4.7.2 Top Products/Product Portfolio
      • 6.4.7.3 Top Competitors
      • 6.4.7.4 Target Customers
      • 6.4.7.5 Key Personal
      • 6.4.7.6 Analyst View
    • 6.4.8 FHC
      • 6.4.8.1 Overview
      • 6.4.8.2 Top Products/Product Portfolio
      • 6.4.8.3 Top Competitors
      • 6.4.8.4 Target Customers
      • 6.4.8.5 Key Personal
      • 6.4.8.6 Analyst View
    • 6.4.9 Integra LifeSciences Corporation
      • 6.4.9.1 Overview
      • 6.4.9.2 Top Products/Product Portfolio
      • 6.4.9.3 Top Competitors
      • 6.4.9.4 Target Customers
      • 6.4.9.5 Key Personal
      • 6.4.9.6 Analyst View
    • 6.4.10 SURGLASSES Inc.
      • 6.4.10.1 Overview
      • 6.4.10.2 Top Products/Product Portfolio
      • 6.4.10.3 Top Competitors
      • 6.4.10.4 Target Customers
      • 6.4.10.5 Key Personal
      • 6.4.10.6 Analyst View
    • 6.4.11 HRS Navigation
      • 6.4.11.1 Overview
      • 6.4.11.2 Top Products/Product Portfolio
      • 6.4.11.3 Top Competitors
      • 6.4.11.4 Target Customers
      • 6.4.11.5 Key Personal
      • 6.4.11.6 Analyst View
    • 6.4.12 Augmedics
      • 6.4.12.1 Overview
      • 6.4.12.2 Top Products/Product Portfolio
      • 6.4.12.3 Top Competitors
      • 6.4.12.4 Target Customers
      • 6.4.12.5 Key Personal
      • 6.4.12.6 Analyst View

7 Research Methodology

  • 7.1 Data Sources
    • 7.1.1 Primary Data Sources
    • 7.1.2 Secondary Data Sources
    • 7.1.3 Data Triangulation
  • 7.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Global Stereotactic Neuro-Navigation System Market (by Scenario), $Million, 2025, 2029, and 2035
  • Figure 2: Global Stereotactic Neuro-Navigation System Market, $Million, 2024 and 2035
  • Figure 3: Stereotactic Neuro-Navigation System Market (by Application), $Million, 2024, 2029, and 2035
  • Figure 4: Stereotactic Neuro-Navigation System Market (by End User), in Million, 2024, 2029, and 2035
  • Figure 5: Organization of the Health System in the U.S.
  • Figure 6: Number of Patents Filed, January 2021-April 2025
  • Figure 7: FDA Classification
  • Figure 8: EU Classification
  • Figure 9: NHS Classification
  • Figure 10: Japan Federation of Medical Devices Associations (JFMDA) Classification
  • Figure 11: NMPA Classification
  • Figure 12: Supply Chain and Risks within the Supply Chain
  • Figure 13: Prevalence of Parkinson's Disease (by Region), 2016-2021
  • Figure 14: Increasing Incidence of CNS Brain Tumor Cases (by Region), 2022, 2025, 2035, and 2045
  • Figure 15: Increasing Aging Population Globally, Million, 2020-2023
  • Figure 16: Global Stereotactic Neuro-Navigation System Market (by Product), $Million, 2024,2029, and 2035
  • Figure 17: Global Stereotactic Neuro-Navigation System Market, by Product, by Neuro-Navigation Systems, $Million, 2023-2035
  • Figure 18: Global Stereotactic Neuro-Navigation System Market, by Neuro-Navigation Systems, $Million, 2023-2035
  • Figure 19: Stealth Station Navigation System, Installed Base, 2023-2035
  • Figure 20: Stealth Station Navigation System, Unit Sold, 2023-2035
  • Figure 21: Global Stereotactic Neuro-Navigation System Market, Neuro-Navigation Systems, Stealth Station Navigation System, $Million, 2023-2035
  • Figure 22: Curve Navigation System, Installed Base, 2023-2035
  • Figure 23: Curve Navigation System, Unit Sold, 2023-2035
  • Figure 24: Global Stereotactic Neuro-Navigation System Market, by Neuro-Navigation Systems, Curve Navigation, $Million, 2023-2035
  • Figure 25: Q Guidance System, Installed Base, 2023-2035
  • Figure 26: Q Guidance System, Unit Sold, 2023-2035
  • Figure 27: Global Stereotactic Neuro-Navigation System Market, by Neuro-Navigation Systems, Q Guidance System $Million, 2023-2035
  • Figure 28: easyNav, Installed Base, 2023-2035
  • Figure 29: easyNav, Unit Sold, 2023-2035
  • Figure 30: Global Stereotactic Neuro-Navigation System Market, by Neuro-Navigation Systems, easyNav, $Million, 2023-2035
  • Figure 31: 7D Surgical System, Installed Base, 2023-2035
  • Figure 32: 7D Surgical System, Unit Sold, 2023-2035
  • Figure 33: Global Stereotactic Neuro-Navigation System Market, by Neuro-Navigation Systems, 7D Surgical System, $Million, 2023-2035
  • Figure 34: Xvision-Spine System, Installed Base, 2023-2035
  • Figure 35: Xvision-Spine System, Unit Sold, 2023-2035
  • Figure 36: Global Stereotactic Neuro-Navigation System Market, by Neuro-Navigation Systems, Xvision-Spine System, $Million, 2023-2035
  • Figure 37: Caduceus S (AR) System, Installed Base, 2023-2035
  • Figure 38: Caduceus S (AR), Unit Sold, 2023-2035
  • Figure 39: Global Stereotactic Neuro-Navigation System Market, by Neuro-Navigation Systems, Caduceus S (AR), $Million, 2023-2035
  • Figure 40: Global Stereotactic Neuro-Navigation System Market, Stereotactic Frame Units, $Million, 2023-2035
  • Figure 41: Global Stereotactic Neuro-Navigation System Market (by Application), $Million, 2023-2035
  • Figure 42: Global Stereotactic Neuro-Navigation System Market, Spinal, $Million, 2023-2035
  • Figure 43: Global Stereotactic Neuro-Navigation System Market, Cranial, $Million, 2023-2035
  • Figure 44: Global Stereotactic Neuro-Navigation System Market (by End User), $Million, 2023-2035
  • Figure 45: Global Stereotactic Neuro-Navigation System Market, Hospitals and Clinics, $Million, 2023-2035
  • Figure 46: Global Stereotactic Neuro-Navigation System Market, Ambulatory Surgical Centers, $Million, 2023-2035
  • Figure 47: North America Stereotactic Neuro-Navigation Market, Spinal Navigation Surgery, Procedure Volume, Thousands, 2023-2035
  • Figure 48: North America Stereotactic Neuro-Navigation Market, Cranial Stereotactic Surgery, Procedure Volume, Thousands, 2023-2035
  • Figure 49: North America Stereotactic Neuro-Navigation Market, $Million, 2023-2035
  • Figure 50: Incidences of Neurological Disorders in U.S., Million, 2018-2021
  • Figure 51: U.S. Stereotactic Neuro-Navigation System Market, $Million, 2023-2035
  • Figure 52: Incidences of Neurological Disorders in Canada, Million, 2018-2021
  • Figure 53: Canada Stereotactic Neuro-Navigation System Market, $Million, 2023-2035
  • Figure 54: Europe Stereotactic Neuro-Navigation Market, Spinal Navigation Surgery, Procedure Volume, Thousands, 2023-2035
  • Figure 55: Europe Stereotactic Neuro-Navigation Market, Cranial Stereotactic Surgery, Procedure Volume, Thousands, 2023-2035
  • Figure 56: Europe Stereotactic Neuro-Navigation Market, $Million, 2023-2035
  • Figure 57: Incidences of Neurological Disorders in U.K., Million, 2018-2021
  • Figure 58: U.K. Stereotactic Neuro-Navigation System Market, $Million, 2023-2035
  • Figure 59: Incidences of Neurological Disorders in Germany, Million, 2018-2021
  • Figure 60: Germany Stereotactic Neuro-Navigation System Market, $Million, 2023-2035
  • Figure 61: Incidences of Neurological Disorders in France, Million, 2018-2021
  • Figure 62: France Stereotactic Neuro-Navigation System Market, $Million, 2023-2035
  • Figure 63: Incidences of Neurological Disorders in Rest-of-Europe, Million, 2018-2021
  • Figure 64: Rest-of-Europe Stereotactic Neuro-Navigation System Market, $Million, 2023-2035
  • Figure 65: Asia Pacific Stereotactic Neuro-Navigation Market, Spinal Navigation Surgery, Procedure Volume, Thousands, 2023-2035
  • Figure 66: Asia Pacific Stereotactic Neuro-Navigation Market, Cranial Stereotactic Surgery, Procedure Volume, Thousands, 2023-2035
  • Figure 67: Asia Pacific Stereotactic Neuro-Navigation Market, $Million, 2023-2035
  • Figure 68: Incidences of Neurological Disorders in Japan, Million, 2018-2021
  • Figure 69: Japan Stereotactic Neuro-Navigation System Market, $Million, 2023-2035
  • Figure 70: Incidences of Neurological Disorders in China, Million, 2018-2021
  • Figure 71: China Stereotactic Neuro-Navigation System Market, $Million, 2023-2035
  • Figure 72: Incidences of Neurological Disorders in Rest-of-Asia-Pacific, Million, 2018-2021
  • Figure 73: Rest-of-Asia-Pacific Stereotactic Neuro-Navigation System Market, $Million, 2023-2035
  • Figure 74: Rest-of-the-World Stereotactic Neuro-Navigation Market, Spinal Navigation Surgery, Procedure Volume, Thousands, 2023-2035
  • Figure 75: Rest-of-the-World Stereotactic Neuro-Navigation Market, Cranial Stereotactic Surgery, Procedure Volume, Thousands, 2023-2035
  • Figure 76: Rest-of-the-World Stereotactic Neuro-Navigation Market, $Million, 2023-2035
  • Figure 77: Strategic Initiatives, January 2017-May 2025
  • Figure 78: Data Triangulation
  • Figure 79: Top-Down and Bottom-Up Approach
  • Figure 80: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Competitive Landscape Snapshot
  • Table 3: Some of the Key Developments
  • Table 4: CPT Coding
  • Table 5: Inpatient Reimbursement
  • Table 6: Medical Devices Classification Medical Devices in Japan
  • Table 7: Regulatory Process in RoW
  • Table 8: Price of Stereotactic Neuro-Navigation System
  • Table 9: Drivers, Restraints, and Opportunities: Current and Future Impact Assessment
  • Table 10: Comparison between Various Navigation-Assisted Surgeries Over Conventional Surgeries
  • Table 11: Sources of Error in Navigated Surgery
  • Table 12: Cost of Acquisition of Key Neuro-Navigation Systems
  • Table 13: Stealth Station Navigation System, Average Selling Price, (in $), 2024
  • Table 14: Curve Navigation System, Average Price, (in $), 2024
  • Table 15: Q Guidance System, Average Pricing, (in $), 2024
  • Table 16: easyNav, Average Pricing, (in $), 2024
  • Table 17: 7D Surgical System, Average Pricing, (in $), 2024
  • Table 18: Xvision-Spine System, Average Pricing, (in $), 2024
  • Table 19: Caduceus S (AR), Average Pricing, (in $), 2024
  • Table 20: Global Stereotactic Neuro-Navigation System Market, Stereotactic Frame Units (by Type), $Million, 2023-2035
  • Table 21: Global Stereotactic Neuro-Navigation System Market (by Region), $Million, 2023-2035
  • Table 22: U.S. Incidences of Neurological Disorders, By Disease Type, 2018-2020
  • Table 23: Canada Incidences of Neurological Disorders, By Disease Type, 2018-2020
  • Table 24: U.K. Incidences of Neurological Disorders, By Disease Type, 2018-2021
  • Table 25: Germany Incidences of Neurological Disorders, By Disease Type, 2018-2020
  • Table 26: France Incidences of Neurological Disorders, By Disease Type, 2018-2020
  • Table 27: Rest-of-Europe Incidences of Neurological Disorders, By Disease Type, 2018-2020
  • Table 28: Japan Incidences of Neurological Disorders, By Disease Type, 2018-2020
  • Table 29: China Incidences of Neurological Disorders, By Disease Type, 2018-2020
  • Table 30: Rest-of-Asia-Pacific Incidences of Neurological Disorders, By Disease Type, 2018-2020
  • Table 31: Some of the Strategies and Development, January 2017-May 2025
  • Table 32: Global Stereotactic Neuro-Navigation System Market, Product Benchmarking (by Product)
  • Table 33: Market Share Analysis, 2024